chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around 12 hours after receiving the 2nd dose of Pfizer vaccine (around 1:00am), I began to get extremely tired (similar to the way one gets after taking a sedative). The next morning, I felt run down. I didn't want to get out of bed. Felt like a truck hit me. Very normal reactions so far. Foggy headed. Then got chills and a mild fever some time in the afternoon. Tongue *felt*(?) funny. Difficult to explain the sensation. Taste and tongue feel just felt different than usual. On Saturday (two days after the vaccine), I still felt run down, cold and foggy headed. Attempted to eat a cheese sandwich, but it hurt(!?). Felt like I really burnt my tongue on food, but did not. The rest of the symptoms were 90% gone by Sunday, the 3rd day after vaccine, but tongue still hurt. Noticed a few swollen taste buds on tongue on Monday (4th day after), and a sore on upper R gum area, near canine. It took roughly 5-6 days for tongue to return back to normal. "Odd" feeling remained for a few days more. I had been put off, for some reason, by wanting to drink coffee ever since day 1 after the vaccine. I drank it on Friday, but absolutely didn't want it on Saturday, or since. I have just been drinking tea. It is very strange for me, since I absolutely love(d) coffee and would normally drink several cups a day! Also, side random note: On Tuesday, the 5th day after the vaccine, I had a very random, very strong taste of rosemary while eating lunch (a tuna sandwich, prepared by myself). I didn't put rosemary in it. The taste subsided nearly as quickly as it came, which is odd considering if I were to have bitten into a rosemary leaf (that washow strong it tasted), the taste would have lingered for several more bites. It did not.
Pfizer-BioNTech COVID-19 Vaccine EUA: Patient experienced flushing and dizziness after administration of Pfizer-BioNTech COVID-19 vaccine with blood pressure: 143/90 mmHg and pulse 80 beats per minute. Cold pack applied and patient ambulated and drank water. Five minutes later blood pressure was 137/85 mmHg and pulse was 63 beats per minute and patient continued to report waves of flushing. Patient ate a banana and another cold pack was applied. After another ten minutes patient reported feeling better but stated felt lightheaded. After an additional 20 minutes blood pressure  was 123/76 mmHg and pulse was 78 beats per minute. Patient stated felt much better and was discharged from clinic in stable condition.
1st dose 3 years ago, did not get the second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received the first dose of shingrix on an unknown date, 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. The pharmacist was unable to provide vaccine details. The reporter enquired if the patient need to start over with series. The reporter did not consent to follow-up.
Significant pericardial effusion - Questioning is related to booster vaccine received on 11/4/2021 as reported by patient.  Patient admitted to hospital pending an echo and a cardiology consult.
Severe chills and shaking/shivering plus severe body ache began approx. 12 hours after vaccine. Chills/shaking lasted approx. 2 hours. Followed by feverish feeling (hot skin, no sweating), then alternating cold/hot episodes plus generalized body ache, severe ache in vaccine arm, and fatigue,  lasting approx. 6 hours. Body aches, headache, fatigue and arm ache lasted until approx. 11 pm the following night (approx. 24 hours total).
Information has been received from a physician concerning a 72 year old male patient with heart condition who in August 2007, was vaccinated with ZOSTAVAX. Concomitant therapy included unspecified antiviral and pain medication. In February 2009, the patient developed a bad case of shingles after receiving ZOSTAVAX. The physician stated that the shingles was from the neck up, v1 and v2. The patient also developed Herpes Zoster ophthalmic and had ophthalmic involvement. Per the physician, the patient was hospitalized for an unknown length of time but the physician attributed it to a heart condition. No further information is available.
My MOTHER had a health condition, diabetes and heart problems, she was at home with palliative care, due to her condition, she was fine in the last month she was able to walk, shower, eat alone, she felt happy to be able to recover, she got the vaccine because the doctor advised her, the same day she got fever, and began to feel fatigued, 3 days later my mother died, she had heart attack from shortness of breath.
Pt complains of asthenia, arthralgia, arthritis, myalgia soon after injection
Joint pain in all joints, most severe in my right wrist; numbness in feet; swelling in fingers and in toes
Patient began feeling like tongue was numb after approximately 12 minutes. She was taken to the emergency room immediately and felt short of breath, flushed, numbness in limbs, and felt like throat and tongue were numb.  Appeared in distress and began on 4 L of oxygen per nasal cannula (SPO2 remained at 100%).  Epinephrine 0.3 mg was given IM at 1501, Benadryl 50 mg was given IM at 1502 and Alprazolam 0.5 mg PO at 1520.  Patient's BP was 152/91 at 1501 but decreased back down to 133/63 at 1508.  Heart rate remained in the 80's and respiratory rate decreased from 24 at 1501 to 20 at 1521
2 1/2 days later I broke out in a large rash/hive on the right side of my neck. It started behind by ear and ran down  about 4 inches. It was raised and while not painful, it was uncomfortable. It started to dissipate 3 days later (today)
Site of injection is hard; Site of injection is painful; Site of injection is swollen; Many side effects (flu like); Swollen lymph nodes in neck and a really painful one under arm pit/enlarged lymph node; Malaise; Muscle aches; Temperature; Headache; Pain in left armpit; This case was reported by a consumer and described the occurrence of injection site induration in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th September 2019, the patient received the 1st dose of Shingrix. In September 2019, 1 day after receiving Shingrix, the patient experienced injection site induration, injection site pain, injection site swelling, influenza-like symptoms, lymphadenopathy cervical, malaise, muscle pain, fever, headache and axillary pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injection site induration, injection site pain, injection site swelling, influenza-like symptoms and malaise were unknown and the outcome of the lymphadenopathy cervical, fever, headache and axillary pain were not recovered/not resolved and the outcome of the muscle pain was recovering/resolving.   It was unknown if the reporter considered the injection site induration, injection site pain, injection site swelling, influenza-like symptoms, lymphadenopathy cervical, malaise, muscle pain, fever, headache and axillary pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient recieved shingrix and had many side effects flu like symptoms. The patient also had swollen lymph nodes in neck and a painful one under my arm pit. The patient had malaise, muscle aches, temperature, Headache, swollen lymph node in neck and pain in her left arm pit yesterday. The patient has worse arm pit pain and an enlarged lymph node. She noted the site of the injection was hard, swollen and painful. She has taken Tylenol and did not feel the muscle aches are better. She still has slight headache and temperature today. She did not believe the lymph node in her left arm pit was decreased in size. The one from her neck has resolved completely.
Vaccination was administered 12/6/07 at 2:30pm Noticed redness and itching on 12/8/07 at 5:00am.
Mildly itchy rash from neck to ankles; Fine rash at injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH PRURITIC (Mildly itchy rash from neck to ankles) and VACCINATION SITE RASH (Fine rash at injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Mildly itchy rash from neck to ankles) and VACCINATION SITE RASH (Fine rash at injection site). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Mildly itchy rash from neck to ankles) and VACCINATION SITE RASH (Fine rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.
This is a spontaneous report from a contactable consumer. A 85-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Feb2021 (at the age of 85-years-old) as a single dose for COVID-19 immunisation. Medical history included stage 1 prostate cancer. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included unspecified medication for stage 1 prostate cancer from an unknown date and unknow if ongoing. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Feb2021, the patient experienced pain in upper arms. The event pain in upper arms did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event pain in upper arms was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA (flu/recurrent low grade flu), VACCINATION SITE PAIN (pain in arm/sore right arm) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 010M20A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis.    The patient's past medical history included Knee surgery NOS (in 1989 and 1990) and Colectomy NOS (Patient had surgeries for his ostomy pouch for over the next 20 years when his colon was removed.) in 1984. Previously administered products included for an unreported indication: CORTISONE (For Ulcerative colitis), SULFASALAZINE (For Ulcerative colitis) and PREDNISONE (For Ulcerative colitis). Concurrent medical conditions included Ulcerative colitis since December 1981, Diabetes and Arthritis. Concomitant products included IRON for Anemia, TRIAMCINOLONE ACETONIDE for Eczema, MESALAZINE (CANASA) for Inflammation, FORVIA for Ulcerative colitis, CYANOCOBALAMIN (VIT B12), TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), AZATHIOPRINE and COLESEVELAM for an unknown indication.   In October 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg every two weeks. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced INFLUENZA (flu/recurrent low grade flu), VACCINATION SITE PAIN (pain in arm/sore right arm) and HEADACHE (headache). On 06-Feb-2021, VACCINATION SITE PAIN (pain in arm/sore right arm) had resolved. On 07-Feb-2021, INFLUENZA (flu/recurrent low grade flu) had resolved. At the time of the report, HEADACHE (headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 100 (High) 100 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Patient's medical history was corrected and historical drugs were added. Suspect details were updated.
SEVERE LETHARGY, WEAKNESS  FOR 36 HOURS, MILD HEADACHE, WHEAL 4X4 CM ABOUT 2 INCHES BELOW INJECTION
DTaP on 7/30 left deltoid 7/31 c/o dizziness. but no fever, vomit or sign of illness.   itchy red area around site of injection.  approx 10 cm, with some swelling, edges are not sharply defined
On July 20th about lunch time I started with a fever chills, aches and I had her take me to urgent care I took a rapid test it was negative. I continued to have a fever that move 101-103. I took medication to lower my fever it never went away. On Sunday 25th I didn't have a fever I still didn't feel well. On Monday the 26th I was going to go to work, I started vomiting uncontrollably and I rode in ambulance. I could not breathe or walk, I was so weak. They tested me again test came back positive for Covid. I did the monoclonal infusion. I was in low 80s for my oxygen and they gave me supplemental oxygen which brought it up to high 80s and low 90s. They did not have a bed said someone would have to die or go home they called near by hospital. No beds available so they sent me home with supplemental oxygen and monitored my oxygen that was set up to my smart home. I'm still really weak and fatigued, exhausted and shortness of breath. I'm getting better just really slow.
12/30/2021: Event occurred after 2nd vaccine. 87-year-old female with history of dementia, Parkinson's, aortic aneurysm, hyperlipidemia, HTN; presented to the ED today for increased altered mental status. patient was nonresponsive to daughter's questioning.  Pt is hemodynamically stable, and afebrile. Respiratory viral panel positive for Covid. Chest X-Ray showed no acute cardiopulmonary process. Treated with Remdesivir 5 day course (12/30-01/03). Decadron 10mg (12/30), and 6mg (12/31-01/04)
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date in 2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions.  Subsequent to patient's inoculation, patient was treated by a healthcare provide for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.   The outcome of shingles was reported as not recovered.   The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
Heavy sinus drainage, heavy coughing, mild fever, mild headache. Started a course of Paxlovid on 10/6/2022 and symptoms were almost completely resolved by 10/8/2022.
PT REPORTED TO PHARMACY TODAY THAT 30-45 MINUTES  FOLLOWING THE PFIZER COVID VACCINE, SHE HAD EXTREME VOMITING.  AMBULANCE HAD TO BE CALLED AND WENT TO ER---SAID THEY GAVE HER PAIN MED AND IV FLUIDS  AND THEN SENT HOME.  THEY FELT LIKE IT WAS DUE TO THE COVID VACCINE.  SHE ALSO HAD DIARRHEA, STOMACH CRAMPS  AND A SEVERE HEADACHE.  ON 8/5, THE NEXT DAY SHE HAD SLIGHT NAUSEA AND A MILD HEADACHE.   TODAY, ON 8/6 SHE STILL HAS A MILD HEADACHE BUT FEELS MUCH BETTER
Cardiac  rhythm problems and inflammation (pain) Super increase - needed to take Metoprolol on a daily basis - have not had to take in 2 years.
My period has come 10 days early in June and 11 days early in July, and has been significantly heavier than normal.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VAQTA lot # N008823 for prophylaxis. The vaccine was exposed to a temperature ranges between 47°Fahrenheit (F) to 77°F, during a time frame of 30 minutes wich was call by a data logger with no previous temperature excursions. This is one of several reports from the same source.; Sender's Comments: US-009507513-1708USA002910: US-009507513-1708USA004847:
Intermittent severe burning pain in my hands along the bones in my fingers between the joints. This is new. Overall worsening of arthritis symptoms in knees and back. Previously I could be treated with dexamethasone 1.5 mg per day to get some relief without weight gain or insomnia. Since vaccination, I am unable to take dexamethasone without rapid onset of insomnia, rapid weight gain and increased blood sugars. Previously I took 1.5 mg 4 days a week without side effects, but cannot take it more than 1 or 2 days now, and onset of side effects is immediate.
Dose was prepared on Friday 01/21/2022, was in a syringe left over from Friday 21 vaccination. The Nurse thought it was from today's batch, she administered it by mistake to the child. It was mixed 72 hours ago. I spoke with Pfizer Pharmaceutical company, they advised me to contact the CDC. The CDC recommended repeating the dose today. Spoke to the mother explained the mistake,  asked her to come back to give the child another dose, mother stated that she is not coming back.
Pain in left arm - starts in the upper arm, continues near elbow and in hand and wrist. Almost identical to type of pain and nerve path when I had shingles in the other arm 2.5 months ago, only not quite as severe. This started one week after the shot, feels better for brief times but the pains have not gone away. Left shoulder and neck pain/stiffness started as well sometime after the arm/hand pain began. Pain seems to mostly stem from and is the sharpest near the deltoid and bicep meet.  IB Profen helps the pain a very small amount. The pain started on June 9 and has only become slightly better since then.
The patient experienced fatigue which has not gone away. The patient has gone to see her Physician about this fatigue. All test results are normal; redness at injection site; swelling at injection site; itching at injection site; body aches; headache; chills; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SPIRONOLACTONE, ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ALPRAZOLAM (XANAX), FLUOXETINE HYDROCHLORIDE (PROZAC) and PRAVASTATIN for an unknown indication.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (body aches), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever). 19-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itching at injection site). On an unknown date, the patient experienced FATIGUE (The patient experienced fatigue which has not gone away. The patient has gone to see her Physician about this fatigue. All test results are normal). On 21-Mar-2021, VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE PRURITUS (itching at injection site) had resolved. At the time of the report, PAIN (body aches), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown and FATIGUE (The patient experienced fatigue which has not gone away. The patient has gone to see her Physician about this fatigue. All test results are normal) had not resolved.            Treatment details not provided.    This case was linked to MOD-2021-350614 (Patient Link).
5 or 6 drops of vaccine dropped on patient's arm; syringe malfunction; A spontaneous report was received from a pharmacist concerning an unknown age and gender patient who experienced syringe malfunction and 5 or 6 drops of vaccine dropped on patient's arm during administration of Moderna's COVID-19 vaccine.  Patient medical history was not provided. No relevant concomitant medications were reported.  On 11 Feb 2021, patient received their one of two planned doses of mRNA-1273 (Lot/ batch number: unknown) intramuscularly for the prophylaxis of COVID-19 infection.  On 11 Feb 2021, when they administered the vaccine to a patient, there was a syringe malfunction and 5 or 6 drops of vaccine dropped on patient's arm during administration of Moderna's COVID-19 vaccine. Treatment for the event was not provided.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, syringe malfunction and 5 or 6 drops of vaccine dropped on patient's arm during administration of Moderna's COVID-19 vaccine, were considered resolved.; Reporter's Comments: This report refers to a case of vaccine underdose and syringe malfunction, for mRNA-1273, lot number unknown, with no associated AEs. Causality of these events is not applicable.
She will not take the second vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received and event stomach pain was removed as patient denied reporting any side effects.